Clinical Trial: Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
Study Status: Completed
Recruit Status: RECRUITING
Condition: Type 1 Diabetes
Study Type: INTERVENTIONAL
Official Title: Using Closed-Loop Artificial Pancreas Technology to Reduce Glycemic Variability and Subsequently Improve Cardiovascular Health in Type 1 Diabetes
Brief Summary:
This study will examine the potential cardiovascular effect(s) of artificial pancreas (AP) technology in patients with type 1 diabetes.AP technology is a system of devices that closely mimics the glucose-regulating function of a healthy human pancreas.It includes an insulin pump and a continuous glucose monitor (CGM).In this study, the investigators will research whether improvements in blood glucose levels and blood glucose variability will in turn decrease biomarkers of inflammation and endothelial dysfunction…
Read more